Lexicon Pharmaceuticals reported $276K in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 7.34B 22M Sep/2026
Acadia Pharmaceuticals USD 40.36M 68.31M Sep/2026
Agios Pharmaceuticals USD 37.84M 2.09M Sep/2026
Akebia Therapeutics USD 18.7M 5.68M Sep/2026
Alnylam Pharmaceuticals USD 105.91M 8.8M Sep/2026
AstraZeneca USD 6.93B 362M Jun/2026
BioMarin Pharmaceutical USD 1.8B 13.54M Sep/2026
Coherus Biosciences USD 5.67M 842K Jun/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Halozyme Therapeutics USD 132.61M 4.52M Sep/2026
Illumina USD 667M 38M Sep/2026
Insmed USD 163.95M 21.56M Sep/2026
J&J USD 15.38B 233M Sep/2026
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
MacroGenics USD 9.5M 1.59M Mar/2026
MannKind USD 48.47M 4.05M Sep/2026
Merck USD 6.16B 43M Sep/2026
Moderna USD 313M 33M Sep/2026
Novartis USD 6.1B 116M Sep/2026
PTC Therapeutics USD 109.33M 17.98M Sep/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Sarepta Therapeutics USD 876.12M 28.15M Sep/2026
Thermo Fisher Scientific USD 5.64B 16M Sep/2026
Ultragenyx Pharmaceutical USD 59M 0 Sep/2026
United Therapeutics USD 201.9M 8.1M Sep/2026
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025